文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
James B. Hall
发表
A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies.
H. Burris, U. Matulonis, F. Muggia, 2007, Gynecologic oncology.